Calian Group (CGY) AI Stock Analysis

• Market Cap: C$597.13M
• Dividend Yield: 2.13%
• Average Volume (3M): 29.85K
• Price to Earnings (P/E): 14224.3
• Beta (1Y): 0.78
• Revenue Growth: 3.03%
• EPS Growth: -99.78%
• Country: CA
• Employees: 4,000
• Sector: Industrials
• Sector Strength: 87
• Industry: Specialty Business Services
• EPS (TTM): 0.93
• Shares Outstanding: 11,345,860
• 10 Day Avg. Volume: 24,140
• 30 Day Avg. Volume: 29,850
• PEG Ratio: -121.98
• Price to Book (P/B): 1.84
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 15.09
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: C$59.80
• Price Target Upside: 13.62% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 5

• Rating: 70 Outperform
• Price Target: C$55.00 ▲(4.50%Upside)

Calian Group's stock score reflects a balanced view of its stability and challenges. The strong corporate events and technical indicators provide a positive outlook, while high valuation metrics and mixed earnings call sentiment temper enthusiasm. Improving profitability and managing economic uncertainties are key to future performance.

Calian Group Business Overview & Revenue Model

Company Description

Calian Group Ltd. is a diverse Canadian company that operates in various sectors, providing innovative solutions and services in health, learning, IT and cyber solutions, and advanced technologies. The company is known for its comprehensive range of services that include healthcare delivery, training and education, consulting, and engineering solutions, catering to both public and private sector clients across Canada and internationally.

How the Company Makes Money

Calian Group makes money through a multi-faceted revenue model that capitalizes on its diverse service offerings across different sectors. Key revenue streams include contracts with government and defense organizations for healthcare and training services, IT and cyber solutions for protecting digital infrastructure, and engineering services in the advanced technologies sector. The company also benefits from long-term partnerships and contracts with various public and private sector clients, which provide a steady flow of income. Additionally, Calian occasionally engages in strategic acquisitions to expand its capabilities and market reach, further contributing to its earnings.

Calian Group Financial Statement Overview

Summary

Calian Group demonstrates stability across its financial statements with solid gross margins and effective cash management. However, low net profitability and declining revenue growth present challenges. The balance sheet remains strong with a healthy equity ratio, though returns on equity are limited. Overall, the company is financially stable but must focus on enhancing profitability and sustaining revenue growth.

Income Statement

Calian Group's income statement shows moderate performance. The TTM Gross Profit Margin is healthy at 32.0%, indicating effective cost management. However, the Net Profit Margin is quite low at 0.007%, suggesting limited profitability after expenses. The TTM EBIT Margin stands at 3.7%, and the EBITDA Margin at 7.1%, both indicating moderate operational efficiency. Revenue growth is stable, with a 13.1% growth from 2023 to 2024, but recent TTM data shows a slight decline. Overall, while the company maintains decent margins, the low net profit margin highlights profitability challenges.

Balance Sheet

The balance sheet reflects a stable financial position for Calian Group. The Debt-to-Equity Ratio is 0.51, showing a balanced approach to leveraging debt. The Return on Equity (ROE) is low at 0.015%, indicating limited returns generated from shareholders' equity. The Equity Ratio is robust at 41.5%, suggesting strong capital structure and asset management. Overall, the company maintains a solid equity base, though profitability on equity could improve.

Cash Flow

Calian Group's cash flow statement reveals strong cash management. The Free Cash Flow Growth Rate shows a decline of 49.6% in the latest period, but the Operating Cash Flow to Net Income Ratio is high at 982.4, indicating effective cash generation relative to net income. The Free Cash Flow to Net Income Ratio is also robust at 775.5, underscoring strong cash conversion. Overall, while free cash flow has decreased, the company remains efficient in converting income to cash.

Breakdown	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement
Total Revenue	746.61M	658.58M	582.17M	518.40M	432.32M
Gross Profit	254.01M	204.21M	169.23M	126.74M	89.16M
EBITDA	70.78M	59.27M	56.06M	37.59M	38.79M
Net Income	11.18M	18.89M	13.60M	11.15M	20.36M
Balance Sheet
Total Assets	707.92M	585.72M	547.16M	457.97M	331.05M
Cash, Cash Equivalents and Short-Term Investments	51.79M	33.73M	42.65M	78.61M	24.23M
Total Debt	129.19M	74.76M	26.54M	17.48M	19.59M
Total Liabilities	381.17M	257.35M	241.98M	165.61M	130.65M
Stockholders Equity	326.75M	328.37M	305.19M	292.36M	200.41M
Cash Flow
Free Cash Flow	75.42M	48.34M	35.82M	38.69M	-8.55M
Operating Cash Flow	87.22M	56.77M	43.14M	46.54M	-2.75M
Investing Cash Flow	-99.67M	-79.62M	-72.89M	-56.61M	-35.19M
Financing Cash Flow	30.50M	13.94M	-6.21M	64.44M	45.04M

Calian Group Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 52.63
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CGY, the sentiment is Positive. The current price of 52.63 is above the 20-day moving average (MA) of 50.14, above the 50-day MA of 45.60, and above the 200-day MA of 46.21, indicating a bullish trend. The MACD of 1.54 indicates Positive momentum. The RSI at 72.25 is Negative, neither overbought nor oversold. The STOCH value of 64.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:CGY.

Calian Group Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TCL.B	74 Outperform	C$1.68B	9.44	9.65%	9.42%	-2.58%	100.21%
GDI	74 Outperform	C$789.32M	20.73	7.93%	―	1.49%	152.09%
DXT	72 Outperform	C$611.89M	19.47	15.03%	3.56%	-10.24%	-23.79%
CGY	70 Outperform	C$597.13M	14,224.32	0.01%	2.13%	3.03%	-99.78%
KBL	70 Outperform	C$445.38M	20.22	9.69%	3.48%	16.35%	3.98%
DCM	69 Neutral	C$94.03M	13.05	21.19%	2.94%	-5.30%	―
Sector *	65 Neutral	$10.91B	15.53	5.25%	2.19%	3.15%	-27.00%

Calian Group Corporate Events

Calian Group Earns Dual Recognition for Excellence and Workplace Culture

Calian Group Ltd. has been recognized by TIME Magazine as one of Canada’s Best Companies and by Forbes as one of Canada’s Best Employers for Company Culture. These accolades highlight Calian’s leadership in delivering mission-critical solutions and fostering a supportive workplace culture. The recognition from TIME underscores the company’s commitment to employee satisfaction, revenue growth, and sustainability, while Forbes’ acknowledgment emphasizes Calian’s inclusive and collaborative work environment. These achievements reflect Calian’s dedication to diversity, equity, and inclusion, which are central to its mission of delivering critical outcomes for clients.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$75.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Calian Secures $250M Contract Amendment to Support Canadian Armed Forces

Calian Group Ltd. has announced a $250 million amendment to its Health Care Provider Recruitment contract with Canada’s Department of National Defence, reinforcing its commitment to the Canadian Armed Forces by ensuring the continued delivery of essential health services. This contract amendment consolidates unspent funds from a previous option period with planned funding for the next, contributing to Calian’s $1.6 billion contract backlog, and highlights the company’s ongoing partnership with government and military organizations, bolstering its position as a key player in Canada’s defence sector.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$75.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Calian Group Appoints Chris Pogue as President of Defence & Space

Calian Group Ltd. announced the appointment of Chris Pogue as President of Defence & Space, effective July 7, 2025. This strategic move aims to enhance Calian’s next-generation defence and space capabilities by integrating its Advanced Technologies and Learning business units. Pogue, a seasoned leader with over 20 years of experience, is expected to drive innovation and operational excellence, aligning with Calian’s One Calian 2026 strategy to meet growing global demand. His leadership is anticipated to strengthen Calian’s market position and foster collaboration with defence and space partners, ensuring mission success in an era of complex global challenges.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$75.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Calian Group Reports Mixed Second Quarter Results Amid Economic Uncertainty

Calian Group reported its second-quarter results, highlighting a 13% growth in its defense solutions, driven by increased global security needs. However, the company faced challenges in its ITCS segment due to slower customer demand and strategic investments for long-term growth. Revenue decreased by 4% to $194 million, while adjusted EBITDA fell by 36% to $17 million. Despite withdrawing its guidance due to economic and geopolitical uncertainties, Calian remains optimistic about future growth, supported by strong signings, a robust M&A pipeline, and the recent acquisition of Advanced Medical Solutions.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$80.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Calian Group Expands Northern Healthcare Reach with Acquisition of AMS

Calian Group Ltd. has acquired Advanced Medical Solutions (AMS), a leading provider of remote and emergency healthcare services in Northern Canada. This strategic acquisition aims to enhance healthcare access and outcomes in Canada’s northern regions by combining the expertise and resources of both companies. The partnership will support the expansion of healthcare services in underserved communities, aligning with national priorities and upcoming federal investments in the Arctic region. AMS will operate under Calian during the transition, with a focus on maintaining service continuity and strengthening community partnerships.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$80.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Calian Expands Mental Health Support for Canada’s Public Safety Agencies

Calian Group Ltd. is addressing the increasing demand for psychological services among Canada’s public safety agencies by expanding its mental health support offerings. The company has experienced significant growth, with a 25% increase in fiscal year 2024 and the addition of 17 new and renewed contracts in the first half of FY25. Calian’s services, which include pre-employment assessments and wellness programs, aim to build resilient public safety workforces and reduce mental health challenges. The company’s efforts are crucial in enhancing team performance and community safety, as public safety personnel face high-stress situations that increase their risk of mental health disorders.

Calian Group to Discuss Q2 FY 2025 Results in Upcoming Conference Call

Calian Group Ltd. announced it will hold a conference call on May 14, 2025, to discuss its second-quarter results for the fiscal year 2025, which will be released earlier that day. This announcement underscores Calian’s commitment to transparency and engagement with its stakeholders, as it continues to navigate the competitive landscape in its diverse sectors.

Calian Group Ltd. Expands Board with Appointment of Eric Demirian

Calian Group Ltd. has announced the appointment of Eric Demirian to its Board of Directors, expanding the board to ten members. Demirian brings extensive financial expertise and experience from his roles in various public and private companies, making him a strategic asset for Calian as it continues its growth journey. His appointment is expected to enhance Calian’s ability to navigate complex financial landscapes and drive long-term value for shareholders.